- Expert in the research and development of apoptotic pathways and antibody drug conjugates - MOUNTAIN VIEW, Calif. , Jan. 07, 2020 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a global leader in the research and development of engineered therapeutic IgM antibodies, today announced the